TELO
Telomir Pharmaceuticals, Inc.
1.20$
+2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4.4% | 9.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.0% | 0.0% | 93.5% | 89.6% | 80.1% | 95.6% | 82.0% | 90.9% | 99.0% | 99.3% | 96.0% | 96.4% | |
| 0.0% | 0.0% | 93.5% | 89.6% | 80.1% | 95.6% | 82.0% | 90.9% | 99.0% | 99.3% | 96.0% | 96.4% | |
| 2.4% | 2.7% | 3.7% | 6.2% | 12.5% | – | – | – | – | – | – | – | |
| 1.9% | 6.4% | – | – | – | – | – | – | – | – | – | – | |
| 59.0% | 28.0% | 13.9% | 25.4% | 57.6% | 51.4% | 132.8% | 42.0% | 5.7% | 19.5% | 14.3% | 6.2% | |
| 59.0% | 28.0% | 13.9% | 25.4% | 57.6% | 51.4% | 132.8% | 42.0% | 5.7% | 19.5% | 14.3% | 6.2% | |
| 25.2% | 2.1% | 0.2% | – | 9.0% | 7.1% | 19.0% | 11.3% | 1.3% | 6.5% | 3.5% | – | |
| 9.3% | 14.8% | 6.3% | 18.7% | 48.6% | 44.4% | 113.8% | 30.7% | 4.4% | 7.3% | 4.8% | 3.6% | |
| 41.0% | 72.0% | 86.1% | 74.6% | 42.4% | 48.6% | -32.8% | 58.0% | 94.3% | 80.5% | 85.7% | 93.8% | |
| -89.1% | -294.6% | -580.0% | -1,035.7% | -2,658.2% | -2,310.9% | -6,672.9% | -4,562.0% | -526.2% | -558.6% | -725.5% | -814.8% | |
| 556.7% | 620.3% | 835.7% | 1,408.8% | 2,841.7% | 2,231.1% | 6,059.3% | 3,617.4% | 419.3% | 468.3% | 593.8% | 640.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.